A New Direction for U.S. AI Policy ?An International Bioethical Deliberation (Feb, 2025)
As U.S. AI policy seems to change direction with regulatory barriers being removed in Favour of an innovation-driven approach, the webinar will explore the possible implications of these changes, focusing on responsibility in the medical field. How should responsible AI in medicine be translated into a regulatory approach? The speakers, all well acquainted with various legal systems, will deliberate on these contemporary issues, and other participants are encouraged to share their questions. Participants:
Prof. I. Glenn Cohen, Harvard Law School, A U.S. Legal Perspective
Prof. Vera Lúcia Raposo, NOVA School of Law, An EU Legal Perspective
Tamar Tavory, PhD Candidate, Bar-Ilan University, An Israeli Legal Perspective
Dr. Oren Asman, Tel Aviv University, Moderator
Comments